HYPERPIGMENTATION OF THE SKIN IN PATIENTS WITH BUSULFAN (MYLERAN) THERAPY.
D002066:Busulfan; D017495:Hyperpigmentation; D007938:Leukemia; D007951:Leukemia, Myeloid; D008548:Melanosis; D014116:Toxicology
D002066:Busulfan
BUSULFAN; LEUKEMIA, MYELOCYTIC; MELANOSIS; TOXICOLOGIC REPORT